Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2014

Dec 2, 2014

31046_dirs_2014-12-01_bbd8f489-da2a-4f1e-8b36-1aca6a6f3045.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2014-12-01

Reporting Person: Hirawat Claudia de Oliveira Ribeiro (President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-01 Common Stock M 417 $10.85 Acquired 39194 Direct
2014-12-01 Common Stock S 300 $43.68 Disposed 38894 Direct
2014-12-01 Common Stock S 117 $44.78 Disposed 38777 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-01 Stock Option (right to buy) $10.85 M 417 Disposed 2023-05-15 Common Stock (417) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 194 Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.

F2: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.